Exact Mass: 456.2319
Exact Mass Matches: 456.2319
Found 234 metabolites which its exact mass value is equals to given mass value 456.2319
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Vindoline
Vindoline is a vinca alkaloid, an alkaloid ester, an organic heteropentacyclic compound, a methyl ester, an acetate ester, a tertiary amino compound and a tertiary alcohol. It is a conjugate base of a vindolinium(1+). Vindoline is a natural product found in Catharanthus ovalis, Catharanthus trichophyllus, and other organisms with data available. Vindoline is an indole alkaloid that exhibits antimitotic activity by inhibiting microtubule assembly. (NCI) D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids C1744 - Multidrug Resistance Modulator Vindoline, a vinca alkaloid extracted from the leaves of Catharanthus roseus, weakly inhibits tubulin self-assembly[1]. Vindoline, a vinca alkaloid extracted from the leaves of Catharanthus roseus, weakly inhibits tubulin self-assembly[1].
Phytyl diphosphate
Phytyl diphosphate participates in biosynthesis of steroids as well as porphyrin and metabolism. Phytyl diphosphate is produced from Geranylgeranyl diphosphate in biosynthesis of steroids. [HMDB]. Phytyl diphosphate is found in many foods, some of which are highbush blueberry, wild leek, evergreen huckleberry, and allium (onion). Phytyl diphosphate participates in biosynthesis of steroids as well as porphyrin and metabolism. Phytyl diphosphate is produced from Geranylgeranyl diphosphate in biosynthesis of steroids.
D1927
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
LysoPA(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:5(5Z,8Z,11Z,14Z,17Z)/0:0), in particular, consists of one chain of eicosapentaenoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
N-[(2S)-1-[[(2S)-1-Amino-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N'-hydroxy-2-(2-methylpropyl)butanediamide
Vindoline
11-O-acetyl-8-epi-torilolone 8-O-beta-D-glucopyranoside
1,5,8-Trihydroxy-12,13-dihydro-3,10-dimethyl-5,12-diisopropyldibenzo[a,h]anthracene-6(5H)-one
(+)-chloranthalacatone F|(1aS,5aR,5bR,9aS,10aS,11aR,11bS,11cS,11dS,11eS,11fR,12aS)-3,8,11b,11e-tetramethyl-1,10-dimethylene-1,1a,2,9,9a,10,10a,11,11a,11d,11e,11f,12,12a-tetradecahydrocyclopropa[3,4]cyclopenta[1,2:3,4]cyclopenta[1,2:5,6]biphenyleno[8a,8-b:8b,1-b]difuran-4,7(11bH,11cH)-dione|chloranthalactone A photodimer|Chloranthalactone F
methyl (2beta,12beta,19alpha)-1-[(2E)-3-phenylprop-2-enoyl]aspidospermidin-21-oate|N1-cinnamoyl-12-demethoxycylindrocarine
16-methoxy-cathovaline|Dihydrovindoline ether|Dihydrovindolinether|ent-4alpha-acetoxy-3,6alpha-epoxy-16-methoxy-1-methyl-aspidospermidine-3beta-carboxylic acid methyl ester
9-Hydroxy-gamma-geraniol-1-O-(6-acetyl-3-angelyl)-beta-D-glucopyranoside|9-Hydroxy-gamma-geraniol-1-O-<6-acetyl-3-angelyl>-beta-D-glucopyranoside
Phe Pro Pro Pro
His Ile Ser Thr
His Ile Thr Ser
His Leu Ser Thr
His Leu Thr Ser
His Ser Ile Thr
His Ser Leu Thr
His Ser Thr Ile
His Ser Thr Leu
His Thr Ile Ser
His Thr Leu Ser
His Thr Ser Ile
His Thr Ser Leu
His Thr Thr Val
His Thr Val Thr
His Val Thr Thr
Ile His Ser Thr
Ile His Thr Ser
Ile Met Pro Pro
Ile Asn Asn Pro
Ile Asn Pro Asn
Ile Pro Met Pro
Ile Pro Asn Asn
Ile Pro Pro Met
Ile Ser His Thr
Ile Ser Thr His
Ile Thr His Ser
Ile Thr Ser His
Leu His Ser Thr
Leu His Thr Ser
Leu Met Pro Pro
Leu Asn Asn Pro
Leu Asn Pro Asn
Leu Pro Met Pro
Leu Pro Asn Asn
Leu Pro Pro Met
Leu Ser His Thr
Leu Ser Thr His
Leu Thr His Ser
Leu Thr Ser His
Met Ile Pro Pro
Met Leu Pro Pro
Met Pro Ile Pro
Met Pro Leu Pro
Met Pro Pro Ile
Met Pro Pro Leu
Asn Ile Asn Pro
Asn Ile Pro Asn
Asn Leu Asn Pro
Asn Leu Pro Asn
Asn Asn Ile Pro
Asn Asn Leu Pro
Asn Asn Pro Ile
Asn Asn Pro Leu
Asn Pro Ile Asn
Asn Pro Leu Asn
Asn Pro Asn Ile
Asn Pro Asn Leu
Asn Pro Gln Val
Asn Pro Val Gln
Asn Gln Pro Val
Asn Gln Val Pro
Asn Val Pro Gln
Asn Val Gln Pro
Pro Phe Pro Pro
Pro Ile Met Pro
Pro Ile Asn Asn
Pro Ile Pro Met
Pro Leu Met Pro
Pro Leu Asn Asn
Pro Leu Pro Met
Pro Met Ile Pro
Pro Met Leu Pro
Pro Met Pro Ile
Pro Met Pro Leu
Pro Asn Ile Asn
Pro Asn Leu Asn
Pro Asn Asn Ile
Pro Asn Asn Leu
Pro Asn Gln Val
Pro Asn Val Gln
Pro Pro Phe Pro
Pro Pro Ile Met
Pro Pro Leu Met
Pro Pro Met Ile
Pro Pro Met Leu
Pro Pro Pro Phe
Pro Gln Asn Val
Pro Gln Val Asn
Pro Val Asn Gln
Pro Val Gln Asn
Gln Asn Pro Val
Gln Asn Val Pro
Gln Pro Asn Val
Gln Pro Val Asn
Gln Val Asn Pro
Gln Val Pro Asn
Ser His Ile Thr
Ser His Leu Thr
Ser His Thr Ile
Ser His Thr Leu
Ser Ile His Thr
Ser Ile Thr His
Ser Leu His Thr
Ser Leu Thr His
Ser Thr His Ile
Ser Thr His Leu
Ser Thr Ile His
Ser Thr Leu His
Thr His Ile Ser
Thr His Leu Ser
Thr His Ser Ile
Thr His Ser Leu
Thr His Thr Val
Thr His Val Thr
Thr Ile His Ser
Thr Ile Ser His
Thr Leu His Ser
Thr Leu Ser His
Thr Ser His Ile
Thr Ser His Leu
Thr Ser Ile His
Thr Ser Leu His
Thr Thr His Val
Thr Thr Val His
Thr Val His Thr
Thr Val Thr His
Val His Thr Thr
Val Asn Pro Gln
Val Asn Gln Pro
Val Pro Asn Gln
Val Pro Gln Asn
Val Gln Asn Pro
Val Gln Pro Asn
Val Thr His Thr
Val Thr Thr His
(4S)-3-[(2S,4S)-4-azido-4-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]-2-propan-2-ylbutanoyl]-4-benzyl-1,3-oxazolidin-2-one
10-([1,1-Biphenyl]-4-yl)anthracen-9-yl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Pipendoxifene
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
N-[1-[(1-amino-1-oxopropan-2-yl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N-hydroxy-2-(2-methylpropyl)butanediamide
1-(5Z,8Z,11Z,14Z,17Z-Eicosapentaenoyl)-glycero-3-phosphoric acid
2-[4-[2-(3,5-dimethoxyanilino)-2-oxoethyl]-1-piperazinyl]-N-(4-ethoxyphenyl)acetamide
N-[(S)-[(1S,2R)-1-methyl-2-[(2R)-1-oxo-1-[(phenylmethyl)amino]propan-2-yl]cyclopropyl]-phenylmethyl]carbamic acid (phenylmethyl) ester
3-[(1-cyclopentyl-5-tetrazolyl)-(3,4-dihydro-1H-isoquinolin-2-yl)methyl]-7-methoxy-1H-quinolin-2-one
(2S)-2-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-3-methylbutanoic acid [2-oxo-2-(4-propan-2-ylanilino)ethyl] ester
3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-6-methyl-1H-quinolin-2-one
N(6)-lactobionoylhexane-1,6-diamine
A primary amide formed between lactobionic acid and hexane-1,6-diamine.
N-[(2R,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyloxane-4-carboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyloxane-4-carboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyloxane-4-carboxamide
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
N-[(2S,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
N-[(2R,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
(2S)-N-[3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-2-[[4-(2,5-dioxopyrrolidin-1-yl)-2-sulfanylbutanoyl]amino]-4-methylpentanamide
1-Arachidonoylglycerone 3-phosphate
A 1-acylglycerone 3-phosphate in which the acyl group is specified as arachidonoyl.
methyl (1S,10R,11S,12S,19S)-11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
2-Arachidonoyl-sn-glycero-3-phosphate(2-)
A 2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-arachidonoyl-sn-glycero-3-phosphate; major species at pH 7.3.
(E)-3,7,11,15-tetramethylhexadec-2-en-1-yl diphosphate
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate
1-Arachidonoyl-sn-glycerol 3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-arachidonoyl-sn-glycero-3-phosphate.
TAPI-0
TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC50 of 100 nM. TAPI-0 is a MMP inhibitor and also attenuates TNF-α processing[1][2].